Steinberg D, Carvalho A C, Chesney C M, Colman R W
Am J Med. 1975 Dec;59(6):845-50. doi: 10.1016/0002-9343(75)90470-2.
The patient described had paroxysmal nocturnal hemoglobinuria associated with recurrent arterial as well as venous thrombosis. Study of platelet function revealed hypersensitivity to epinephrine, adenosine 5'phosphate (ADP) and collagen as judged by their ability to aggregate platelets as well as to release 14C serotonin. The release of total nucleotides was also markedly increased over normal with all aggregating agents. The abnormality was localized to the platelet since aggregation occurred when the patient's platelets were resuspended in normal plasma but not when normal platelets were incubated in the patient's plasma. Presumptive evidence for ongoing intravascular coagulation was an increase in fibrinogen derivatives of heavier molecular weight than the native protein presumably a result of thrombin action. However, factor XII was not activated and fibrinolysis was not increased. Complement component levels and antithrombin concentrations were also normal. The findings in this case suggest that hypersensitive platelets may contribute to the intravascular coagulation that is manifested by the increased incidence of thrombosis in patients with paroxysmal nocturnal hemoglobinuria.
该患者患有阵发性夜间血红蛋白尿,伴有反复的动脉和静脉血栓形成。血小板功能研究显示,根据肾上腺素、5'-磷酸腺苷(ADP)和胶原使血小板聚集以及释放14C-5羟色胺的能力判断,患者对这些物质过敏。使用所有聚集剂时,总核苷酸的释放也比正常情况显著增加。由于当患者的血小板重悬于正常血浆中时会发生聚集,而正常血小板在患者血浆中孵育时则不会,所以这种异常定位于血小板。有正在进行血管内凝血的推测性证据是,与天然蛋白质相比,分子量更大的纤维蛋白原衍生物增加,这可能是凝血酶作用的结果。然而,因子XII未被激活,纤维蛋白溶解也未增加。补体成分水平和抗凝血酶浓度也正常。该病例的研究结果表明,过敏的血小板可能导致血管内凝血,这在阵发性夜间血红蛋白尿患者血栓形成发生率增加中表现出来。